progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects

Study identifier:4522IL/0044

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Randomized, Double-Blind, multicenter, trial to assess the effect of high & Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.

Medical condition

Carotid Artery Stenosis

Phase

Phase 3

Healthy volunteers

Study drug

Rosuvastatin

Sex

All

Actual Enrollment

200

Study type

Interventional

Age

18 Years - 150 Years

Date

Study Start Date: 01 Jan 2000

Primary Completion Date: -

Study Completion Date: 01 Aug 2004

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Experimental: 1	-

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1564&filename=CSR-D3560C00044.pdf
Download
CSR-D3560C00044.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

null AstraZeneca Clinical Study Information

800-236-9933

information.center@astrazeneca.com

Investigators

Principal Investigator

Tom Hatsukami

University of Washington, USA